• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Axcel explores dual-track process for Aidian
Axcel explores dual-track process for Aidian

Rothschild and Carnegie have been mandated as sale and IPO advisers, respectively

  • Exits
  • 13 October 2021
HealthCap makes raft of senior appointments
HealthCap makes raft of senior appointments

Nordic-headquartered life sciences and healthcare VC is deploying equity via HealthCap VIII

  • GPs
  • 07 October 2021
ArchiMed invests in Xpress Biologics
ArchiMed invests in Xpress Biologics

Plasmid DNA and protein therapy developer is an investment from the GP's Med II fund

  • Buyouts
  • 05 October 2021
AFB holds EUR 86m first close for second fund
AFB holds EUR 86m first close for second fund

Advent France Biotechnology held a EUR 64.75m final close for its predecessor fund in 2017

  • Venture
  • 30 September 2021
Intriva buys Sequence Care from Horizon
Intriva buys Sequence Care from Horizon

Technology- and service-focused Horizon Capital completed a spin-off from Lyceum Capital in 2018

  • Buyouts
  • 29 September 2021
UK social care reform: threat or opportunity for PE?
UK social care reform: threat or opportunity for PE?

PE players and advisers with experience in the care space weigh in on whether the reform is likely to affect investments

  • Healthcare
  • 24 September 2021
Illumnina Ventures closes second fund on USD 325m
Illumnina Ventures closes second fund on USD 325m

VC operates independently from US business Illumina, a genetic variation and function technology firm

  • UK / Ireland
  • 21 September 2021
Nordic Capital and Avista to sell Acino to ADQ
Nordic Capital and Avista to sell Acino to ADQ

Nordic Capital transferred the company to continuation vehicle Nordic Capital CV1 in 2018

  • Exits
  • 17 September 2021
Sun European names new healthcare managing director
Sun European names new healthcare managing director

Sun recruits Mark Braganza, a former partner at GHO Capital, to spearhead its push into healthcare

  • People
  • 15 September 2021
Astorg, Goldman Sachs to sell HRA Pharma for EUR 1.8bn
Astorg, Goldman Sachs to sell HRA Pharma for EUR 1.8bn

Astorg and Goldman Sachs acquired the French asset for EUR 300m-500m in 2016

  • Exits
  • 09 September 2021
DocPlanner raises round valuing business at USD 1bn
DocPlanner raises round valuing business at USD 1bn

Another undisclosed round is expected within the next year, sources say

  • Expansion
  • 06 September 2021
KKA acquires majority stake in CuraMed Kliniken
KKA acquires majority stake in CuraMed Kliniken

GP has identified two targets to expand the capacity of the mental health clinic chain

  • Buyouts
  • 03 September 2021
Waterland sells Atos Kliniken to ICG
Waterland sells Atos Kliniken to ICG

Waterland formed the orthopaedic clinic chain via a spin-off from portfolio company Media in 2016

  • Exits
  • 01 September 2021
Forbion hires Novo Ventures' Lüneborg
Forbion hires Novo Ventures' Lüneborg

Nanna Lüneborg will be responsible for Forbion's EUR 360m Growth Opportunities Fund I

  • People
  • 01 September 2021
Cardinal Capital to acquire MML-backed Ashdale Care
Cardinal Capital to acquire MML-backed Ashdale Care

A source close to the situation confirmed the deal; it was first reported in the Irish Sunday Times

  • Buyouts
  • 26 August 2021
AGIC to sell Fotona to Vitruvian
AGIC to sell Fotona to Vitruvian

AGIC is to retain a stake in the Slovenia-based medical and dental laser company

  • Buyouts
  • 26 August 2021
Inflexion to acquire Sunovion Pharmaceuticals Europe
Inflexion to acquire Sunovion Pharmaceuticals Europe

Inflexion's previous pharmaceutical sector investments include Rosemont Pharmaceuticals

  • Buyouts
  • 19 August 2021
Charme, Livingbridge sell Witherslack to Mubadala Capital
Charme, Livingbridge sell Witherslack to Mubadala Capital

Both Charme and Livingbridge are to retain minority stakes in the school and care home operator

  • Exits
  • 19 August 2021
FSN secures majority stake in Adragos Pharma
FSN secures majority stake in Adragos Pharma

Deal is the fourth investment from FSN Capital VI, which closed on EUR 1.8bn in June last year

  • Buyouts
  • 09 August 2021
Astorg acquires surgery supplies manufacturer Demetra
Astorg acquires surgery supplies manufacturer Demetra

Keensight merged medical technology businesses Tecres and Aap Biomaterials to form Demetra in 2016

  • Buyouts
  • 06 August 2021
ArchiMed raises EUR 650m in less than two months
ArchiMed raises EUR 650m in less than two months

Fund is double the size of its predecessor, MED II, which is now invested in 11 companies

  • Funds
  • 06 August 2021
TA buys Smiths Medical from parent Smiths Group
TA buys Smiths Medical from parent Smiths Group

Deal gives the medical subsidiary a USD 2.3bn enterprise value

  • Buyouts
  • 03 August 2021
Afinum, SHS sell Evitria to trade
Afinum, SHS sell Evitria to trade

Exit values the Switzerland-based antibody expression specialist at more than EUR 200m

  • Exits
  • 28 July 2021
Capiton raises top-up single asset fund for KD Pharma
Capiton raises top-up single asset fund for KD Pharma

GP completed its first single-asset deal for KD Pharma in 2019, having acquired the company in 2013

  • DACH
  • 28 July 2021
151617
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013